Company news

Quanterix Corporation news in 2022

Quanterix Corporation's news releases, calls and decks from 2022, newest first.

View company

Quanterix Corporation Releases Operating Results for Third Quarter 2022

November 7, 2022

Quanterix Corporation Releases Operating Results for Second Quarter 2022, Announces Business Re-Alignment Plan and Revises 2022 Guidance

August 7, 2022

Quanterix Announces the Resignation of Kevin Hrusovsky as Executive Chairman of Board of Directors

August 7, 2022

Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications in the U.S.

July 26, 2022

Quanterix Announces Appointment of Karen A. Flynn to Board of Directors

June 5, 2022

Quanterix Corporation Releases Operating Results for First Quarter 2022

May 9, 2022

Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022

May 2, 2022

Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis

April 21, 2022

Quanterix’ Simoa® Technology Powers Large, International Comprehensive Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Disease Activity in Multiple Sclerosis (MS) Patients

April 3, 2022

Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021

February 28, 2022

Quanterix Announces New Agreements with Lilly to Advance Alzheimer’s Disease Diagnosis and Treatment

February 28, 2022

Quanterix Announces Executive Leadership Succession Plan

February 28, 2022

Quanterix Provides Operational and Preliminary Financial Highlights

January 12, 2022

Calls in 2022

Decks in 2022